Aug 2026· Ophthalmology and Therapy· Vol 15, pp. 3401 - 3419· 0 citations· 22 references
Medicine
TL;DR
In the initial experience with the WLP and SMILE Pro platforms, WLP achieved better UDVA and more precise astigmatic correction compared with SMILE Pro and had comparable safety and efficacy outcomes to WFO.
Abstract
This study evaluates visual and refractive outcomes of our initial experience using ray-tracing-guided Wavelight Plus (WLP) LASIK and SMILE Pro KLEx carried out by one surgeon at a single center. A retrospective, non-randomized study was conducted at one refractive surgery center. Patients undergoing WLP or SMILE Pro with at least 1 month of postoperative follow-up were included. Outcomes were assessed at 1 and 3 months and included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), safety and efficacy indices, and vector analysis of astigmatism. Additionally, a comparison with wavefront-optimized (WFO) LASIK, an established procedure with a well-refined nomogram at the study center, was provided as an internal benchmark. A total of 160 eyes from 93 patients were analyzed, including 50 eyes treated with WLP, 55 with SMILE Pro, and 55 with WFO. WLP demonstrated significantly better UDVA than SMILE Pro at both 1 month (p < 0.001) and 3 months (p = 0.033) and was more likely to achieve a UDVA of 20/20. Residual astigmatism was significantly lower in the WLP group than in both the WFO and SMILE Pro groups at 1 and 3 months (all p < 0.001). Vector analysis showed a correction index of 1.13 for SMILE Pro, 1.11 for WFO, and 1.08 for WLP at 3 months. In our initial experience with the WLP and SMILE Pro platforms, WLP achieved better UDVA and more precise astigmatic correction compared with SMILE Pro. Additionally, WLP, without the use of a nomogram, had comparable safety and efficacy outcomes to WFO. Based on our initial experience at one center, astigmatic correction appears to be a limiting factor for KLEx platforms in achieving outcomes similar to modern LASIK platforms.
OBJECTIVE
To evaluate the efficacy, safety, refractive accuracy, and stability of WaveLight Plus InnovEyes ray-tracing-guided LASIK (WL Plus LASIK) in myopia and myopic astigmatism.
DESIGN
Prospective, non-randomized interventional study.
SUBJECTS, PARTICIPANTS AND/OR CONTROLS
A total of 800 eyes of 400 patients wi...
Rohit Shetty, Abha A. Shah, Prabhjot Singh et al.· American journal of ophthalm...· 0 citations
Purpose.
To evaluate the dynamics of functional and refractive outcomes, as well as the safety, efficacy, and predictability of transepithelial photorefractive keratectomy (TransPRK) for the correction of myopia and myopic astigmatism using the SCHWIND Amaris 1050RS laser platform at 1, 3, and 12 months postoperativ...
E. N. Eskina, V. A. Parshina, M. K. Movsesyan et al.· Ophthalmology in Russia· 0 citations
Purpose To evaluate the effectiveness and safety of a new trifocal intraocular lens (IOL) in patients with age‐related cataracts 12 months after surgery. Methods This prospective, noncomparative, multicenter study included 122 patients (244 eyes) undergoing cataract surgery with bilateral implantation of the AT ELANA 8...
P. Mojžiš, Andrea Janeková, L. Hrčková et al.· Journal of Ophthalmology· 0 citations
Custom-Q without Q-adjustment is an effective and safe option for myopic PRK, achieving better refractive precision and lower CT reduction per diopter than WFO, with improved control of spherical aberration despite comparable increases in asphericity and RMS-HOAs6mm.
Burak Tanrıverdi, N. Çağıl· European Journal of Ophthalm...· 0 citations
Purpose To evaluate 12-month visual and clinical outcomes after implantation of a monofocal aspheric hydrophobic acrylic intraocular lens (IOL) delivered with a preloaded system. Methods This investigator-initiated, prospective, single-center, uncontrolled feasibility study enrolled 30 patients undergoing unilateral or...
Oliver Hassel, M. K. Hallak, Max K Köppe et al.· Clinical Ophthalmology· 0 citations
Purpose To compare the clinical and patient-reported outcomes following bilateral implantation of partial-depth-of-field enhanced monofocal IOL in subjects achieving bilateral emmetropia vs mini-monovision. Patients and Methods This prospective, non-interventional, multicenter, cross-sectional study included subjects w...
J. G. Parekh, Christopher M. Spearman, J. Micheletti et al.· Clinical Ophthalmology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.